The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of the biomarkers for the prediction of efficacy in the first-line chemotherapy of metastatic colorectal cancer patients using SELDI-TOF-MS and artificial neural networks.
Ying Yuan
No relevant relationships to disclose
Hong Shen
No relevant relationships to disclose
Mo-Dan Li
No relevant relationships to disclose
Chun-Wen Tan
No relevant relationships to disclose
Jie-Kai Yu
No relevant relationships to disclose
Xue-Feng Fang
No relevant relationships to disclose
Shu Zheng
No relevant relationships to disclose